Submissions for variant NM_000019.4(ACAT1):c.1229C>T (p.Ala410Val)

gnomAD frequency: 0.00003  dbSNP: rs767412638

Total submissions: 4

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Illumina Laboratory Services, Illumina	RCV000341325	SCV000366985	uncertain significance	Deficiency of acetyl-CoA acetyltransferase	2018-01-13	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Department of Pediatrics, Gifu University	RCV000341325	SCV000966127	uncertain significance	Deficiency of acetyl-CoA acetyltransferase	2019-05-05	criteria provided, single submitter	research
Labcorp Genetics (formerly Invitae), Labcorp	RCV000341325	SCV002294161	likely pathogenic	Deficiency of acetyl-CoA acetyltransferase	2024-01-31	criteria provided, single submitter	clinical testing	This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 410 of the ACAT1 protein (p.Ala410Val). This variant is present in population databases (rs767412638, gnomAD 0.08%). This missense change has been observed in individual(s) with beta-ketothiolase deficiency (PMID: 28220263). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 302210). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACAT1 protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000341325	SCV002766006	likely pathogenic	Deficiency of acetyl-CoA acetyltransferase	2022-11-17	criteria provided, single submitter	clinical testing	Variant summary: ACAT1 c.1229C>T (p.Ala410Val) results in a non-conservative amino acid change located in the Thiolase, C-terminal domain (IPR020617) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251374 control chromosomes. c.1229C>T has been reported in the literature as a compound heterozygous genotype in at-least one individual affected with clinical and biochemical findings highly suggestive of Alpha-Methylacetoacetic Aciduria (beta-ketothiolase deficiency), a disease with a single genetic etiology (example, Nguyen_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS, n=2; likely pathogenic, n=1). Based on the weigthing of the clinical evidence outlined above, the variant was classified as likely pathogenic.